WS1 Full Gene Sequence Analysis Wolfram Syndrome DIDMOAD Test sale cost 7200 AED
Lung Cancer Panel 5 EGFRKRASBRAFALK1ROS1 Test sale cost 7200 AED Lung Cancer Panel 5 EGFRKRASBRAFALK1ROS1 Test Cost 9,600 د.إ Original price was: 9,600 د.إ.7,200 د.إCurrent price is: 7,200 د.إ.
Lung Cancer Panel 6 EGFR by SequencingALK by IHC ROS1 by FISH Test sale cost 6000 AED Lung Cancer Panel 6 EGFR by SequencingALK by IHC ROS1 by FISH Test Cost 8,000 د.إ Original price was: 8,000 د.إ.6,000 د.إCurrent price is: 6,000 د.إ.
Sale!

WS1 Full Gene Sequence Analysis Wolfram Syndrome DIDMOAD Test Cost

Original price was: 9,600 د.إ.Current price is: 7,200 د.إ.

-25%

The “WS1 Full Gene Sequence Analysis Wolfram Syndrome (DIDMOAD) Test” is a sophisticated diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the WFS1 gene, which are indicative of Wolfram Syndrome. This rare, genetic disorder, also known as DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), presents a combination of symptoms affecting various organs and systems within the body. By analyzing the complete gene sequence, this test can provide crucial information for the accurate diagnosis of Wolfram Syndrome, enabling timely and appropriate management of the condition. The cost of the test is set at 7200 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. Through such detailed genetic testing, DNA Labs UAE plays a vital role in the early detection and treatment planning for individuals affected by this complex syndrome.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

WS1 Full gene sequence Analysis Wolfram Syndrome DIDMOAD Test

Cost: 7200.0 AED

Symptoms, Diagnosis, and Test Details

Wolfram syndrome, also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness), is a rare genetic disorder that affects multiple organ systems. It is caused by mutations in the WFS1 gene, which encodes a protein called wolframin. The WFS1 gene is located on chromosome 4p16.1 and contains 17 exons.

The full gene sequence analysis involves the sequencing of all 17 exons and their adjacent intronic regions. This analysis can be performed using various techniques, such as Sanger sequencing, next-generation sequencing (NGS), or targeted gene panel sequencing.

The mutations in the WFS1 gene can lead to a loss of function of the wolframin protein, which is involved in the regulation of cellular calcium homeostasis, endoplasmic reticulum (ER) stress response, and insulin secretion. The dysfunction of these cellular processes can result in the characteristic clinical features of Wolfram syndrome, such as diabetes mellitus, optic atrophy, deafness, and neurologic abnormalities.

The full gene sequence analysis of WFS1 can help in the diagnosis of Wolfram syndrome and can also identify the specific mutations in the gene. This information can be useful for genetic counseling, as well as for developing targeted therapies for the disorder.

Test Information

Test Name: WS1 Full gene sequence Analysis Wolfram Syndrome DIDMOAD Test

Components: Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer (2ml)

Price: 7200.0 AED

Sample Condition: Peripheral blood/Amniotic Fluid/ Chorionic villi/ Cord blood

Report Delivery: 4-6 weeks

Method: NGS

Test type: Genetics

Doctor: General Physician

Test Department: DNA Labs UAE

Pre Test Information

WS1 Full gene sequence Analysis (Wolfram Syndrome, DIDMOAD) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Conclusion

In conclusion, the full gene sequence analysis of WFS1 is a valuable tool for the diagnosis and management of Wolfram syndrome, a rare genetic disorder with significant clinical implications.

Test Name WS1 Full gene sequence Analysis Wolfram Syndrome DIDMOAD Test
Components Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer (2ml)
Price 7200.0 AED
Sample Condition Peripheral blood\/Amniotic Fluid\/ Chorionic villi\/ Cord blood
Report Delivery 4-6 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information WS1 Full gene sequence Analysis (Wolfram Syndrome, DIDMOAD) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Wolfram syndrome, also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness), is a rare genetic disorder that affects multiple organ systems. It is caused by mutations in the WFS1 gene, which encodes a protein called wolframin.

The WFS1 gene is located on chromosome 4p16.1 and contains 17 exons. The full gene sequence analysis involves the sequencing of all 17 exons and their adjacent intronic regions. This analysis can be performed using various techniques, such as Sanger sequencing, next-generation sequencing (NGS), or targeted gene panel sequencing.

The mutations in the WFS1 gene can lead to a loss of function of the wolframin protein, which is involved in the regulation of cellular calcium homeostasis, endoplasmic reticulum (ER) stress response, and insulin secretion. The dysfunction of these cellular processes can result in the characteristic clinical features of Wolfram syndrome, such as diabetes mellitus, optic atrophy, deafness, and neurologic abnormalities.

The full gene sequence analysis of WFS1 can help in the diagnosis of Wolfram syndrome and can also identify the specific mutations in the gene. This information can be useful for genetic counseling, as well as for developing targeted therapies for the disorder.

In conclusion, the full gene sequence analysis of WFS1 is a valuable tool for the diagnosis and management of Wolfram syndrome, a rare genetic disorder with significant clinical implications.

SKU: TEST-750 Category:

Related products